The use of variable rate intravenous insulin infusion (VRIII) in medical inpatients
The use of variable rate intravenous insulin infusion (VRIII) in medical inpatients - Joint British Diabetes Societies - Inpatient Care Group (JBDS-IP)
This guideline is for the use of variable rate intravenous insulin infusion (VRIII) in adult inpatients with medical conditions and diabetes/hyperglycaemia, who require intravenous administration of insulin to keep their blood glucose within the recommended target range during an acute illness or a period of starvation.
This document, produced by the Joint British Diabetes Societies - Inpatient Care Group (JBDS-IP), is designed to guide non-specialist teams in the appropriate and safe use of VRIII.
JBDS-IP is supported by Diabetes UK, the Association of British Clinical Diabetologists (ABCD) and the Diabetes Inpatient Specialist Nurse UK Group. The aim of JBDS-IP is to improve inpatient diabetes care throughout the UK. This is mainly through the development and use of high quality evidence based guidelines, and through better inpatient care pathways.